Literature DB >> 7681188

Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation.

J Vohra1, S Sathe, R Warren, J Tatoulis, D Hunt.   

Abstract

Mitral valve prolapse (MVP) is a common disorder that, in general, has a good prognosis. Rare occasions of sudden death have been reported in patients with MVP and it is presumed that the basis of sudden death is arrhythmic. We report seven patients with moderate to severe MVP and malignant ventricular arrhythmias. All patients had trivial to mild mitral regurgitation and normal left ventricular function. Three patients presented with syncope, two with out-of-hospital cardiac arrest, and three with recurrent palpitations and presyncope. In a mean follow-up period of 2.5 years (range 6 months to 5 years), two patients died suddenly despite successful control of their nonsustained ventricular tachycardia (VT) with sotalol as shown by ambulatory monitoring. Two patients, who had sustained VT despite antiarrhythmic drug therapy, had mitral valve surgery, however, monomorphic VT could be induced in both even after surgery. The arrhythmias in the remaining three patients are controlled on antiarrhythmic drugs. We conclude that a selected subset of patients with MVP, malignant ventricular arrhythmias, and mild mitral regurgitation are at risk of sudden death. Syncope, inferolateral repolarization changes, complex ventricular ectopy, and a markedly myxomatous valve may be pointers to higher risk of sudden death and mitral valve surgery may not provide control of ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681188     DOI: 10.1111/j.1540-8159.1993.tb01599.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  19 in total

1.  Mitral Valve Prolapse: A Disease of Valve and Ventricle.

Authors:  Robert A Levine; Michael Jerosch-Herold; Roger J Hajjar
Journal:  J Am Coll Cardiol       Date:  2018-08-21       Impact factor: 24.094

2.  Fourier phase analysis of SPECT equilibrium radionuclide angiography in symptomatic patients with mitral valve prolapse without significant mitral regurgitation: assessment of biventricular functional abnormalities suggesting a cardiomyopathy.

Authors:  D Casset-Senon; D Babuty; L Philippe; L Fauchier; V Eder; J P Fauchier; J M Pottier; C Delhomme; P Cosnay
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

3.  Malignant Mitral Valve Prolapse: Risk and Prevention of Sudden Cardiac Death.

Authors:  Yasufumi Nagata; Philippe B Bertrand; Robert A Levine
Journal:  Curr Treat Options Cardiovasc Med       Date:  2022-03-22

4.  Mitral valve prolapse and the association with cutaneous mucin infiltration: ("cardiocutaneous mucinosis").

Authors:  Uzma Farooq; Sonal Choudhary; Michael P McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

5.  Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping.

Authors:  Silvia Pradella; Giulia Grazzini; Marta Brandani; Linda Calistri; Cosimo Nardi; Fabio Mori; Vittorio Miele; Stefano Colagrande
Journal:  Eur Radiol       Date:  2018-08-07       Impact factor: 5.315

6.  Prolonged Tp-e Interval and Tp-e/QT Ratio in Children with Mitral Valve Prolapse.

Authors:  Mustafa Demirol; Cem Karadeniz; Rahmi Ozdemir; Şenay Çoban; Nagehan Katipoğlu; Yılmaz Yozgat; Timur Meşe; Nurettin Unal
Journal:  Pediatr Cardiol       Date:  2016-06-01       Impact factor: 1.655

7.  Reduction in malignant ventricular arrhythmia and appropriate shocks following surgical correction of bileaflet mitral valve prolapse.

Authors:  Vaibhav R Vaidya; Christopher V DeSimone; Namrata Damle; Niyada Naksuk; Faisal F Syed; Michael J Ackerman; Shiva P Ponamgi; Vuyisile T Nkomo; Rakesh M Suri; Peter A Noseworthy; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2016-01-15       Impact factor: 1.900

8.  Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.

Authors:  An H Bui; Sébastien Roujol; Murilo Foppa; Kraig V Kissinger; Beth Goddu; Thomas H Hauser; Peter J Zimetbaum; Long H Ngo; Warren J Manning; Reza Nezafat; Francesca N Delling
Journal:  Heart       Date:  2016-08-11       Impact factor: 5.994

9.  Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography.

Authors:  Pedro Carmo; Maria J Andrade; Carlos Aguiar; Rui Rodrigues; Raquel Gouveia; José A Silva
Journal:  Cardiovasc Ultrasound       Date:  2010-12-09       Impact factor: 2.062

10.  Antemortem and Post-Mortem Characteristics of Lethal Mitral Valve Prolapse Among All Countywide Sudden Deaths.

Authors:  Francesca N Delling; Sidney Aung; Eric Vittinghoff; Shiktij Dave; Lisa J Lim; Jeffrey E Olgin; Andrew Connolly; Ellen Moffatt; Zian H Tseng
Journal:  JACC Clin Electrophysiol       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.